Home/Filings/4/0001127602-21-015775
4//SEC Filing

Boratto Eva C 4

Accession 0001127602-21-015775

CIK 0000064803other

Filed

May 5, 8:00 PM ET

Accepted

May 6, 5:52 PM ET

Size

14.8 KB

Accession

0001127602-21-015775

Insider Transaction Report

Form 4
Period: 2021-05-04
Boratto Eva C
SVP, Cont & Chief Acct Officer
Transactions
  • Sale

    Common Stock

    2021-05-04$80.00/sh4,905$392,400115,331.045 total
Holdings
  • Stock Option

    Exercise: $102.26From: 2016-04-01Exp: 2022-04-01Common Stock (27,392 underlying)
    27,392
  • Stock Option

    Exercise: $78.05From: 2018-04-03Exp: 2024-04-03Common Stock (35,062 underlying)
    35,062
  • Stock Option

    Exercise: $62.21From: 2019-04-01Exp: 2025-04-01Common Stock (35,030 underlying)
    35,030
  • Stock Option

    Exercise: $74.30From: 2022-04-01Exp: 2031-04-01Common Stock (103,663 underlying)
    103,663
  • Common Stock (restricted)

    2,242
  • Stock Option

    Exercise: $54.19From: 2020-04-01Exp: 2029-04-01Common Stock (202,007 underlying)
    202,007
  • Stock Option

    Exercise: $58.34From: 2021-04-01Exp: 2030-04-01Common Stock (168,956 underlying)
    168,956
  • Stock Option

    Exercise: $104.82From: 2017-04-01Exp: 2023-04-01Common Stock (21,509 underlying)
    21,509
Footnotes (9)
  • [F1]All sales were effected pursuant to a Rule 10b5-1 plan.
  • [F2]Option became exercisable in four equal annual installments, commencing 4/1/2016.
  • [F3]Option becomes exercisable in four equal annual installments, commencing 4/1/2017.
  • [F4]Option became exercisable in four equal annual installments, commencing 4/3/2018.
  • [F5]Option became exercisable in four equal annual installments, commencing 4/1/2019.
  • [F6]Option became exercisable in four equal annual installments, commencing 4/1/2020.
  • [F7]The number of shares subject to the option were calculated using a 30-day average price.
  • [F8]Options became exercisable in four equal annual installments, commencing 4/1/2021.
  • [F9]Option becomes exercisable in four equal annual installments, commencing 4/1/2022.

Issuer

CVS HEALTH Corp

CIK 0000064803

Entity typeother

Related Parties

1
  • filerCIK 0001580827

Filing Metadata

Form type
4
Filed
May 5, 8:00 PM ET
Accepted
May 6, 5:52 PM ET
Size
14.8 KB